Table: Cosmos Pharmaceutical - 9-MTH group results

Cosmos Pharmaceutical

13/04/2026 07:30

Apr 13 (Reuters)- 
             Cosmos Pharmaceutical Corp. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Feb 28, 2026        Feb 28, 2025     May 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            810.38              752.27          1.06 trln  
                 (+7.7 pct)          (+5.2 pct)       (+4.5 pct)  
  Operating         32.02               31.63            40.50    
                 (+1.2 pct)          (+33.2 pct)      (+0.2 pct)  
  Recurring         33.87               33.77            43.20    
                 (+0.3 pct)          (+30.3 pct)      (+0.1 pct)  
  Net               22.75               22.34            31.00    
                 (+1.8 pct)          (+28.7 pct)      (+0.1 pct)  
  EPS            287.02 yen          281.91 yen       391.13 yen  
  Ann Div                             70.00 yen        75.00 yen  
  -Q2 div         37.50 yen           32.50 yen                   
  -Q4 div                             37.50 yen        37.50 yen  
  
  NOTE - Cosmos Pharmaceutical Corp.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T